Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06464926 · ClinicalTrials.gov registry record · NA
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
A NA study of Nausea and Vomiting, sponsored by Enterra Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 148
- Enrollment target
- 17
- Study locations
NCT06464926 is a NA study of Nausea and Vomiting that is actively recruiting participants, run by Enterra Medical. The registered enrollment target is 148 participants, below the 235-participant average among 17 other Nausea trials with a reported enrollment target (37% lower). The trial reports 17 study locations across 11 states.
The verdict
NCT06464926, a NA study of Nausea and Vomiting, is actively recruiting participants, sponsored by Enterra Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
- 17
- Study locations
Study Summary
The purpose of this research study is to determine if the Enterra® Therapy System can decrease nausea and vomiting symptoms and improve the quality of life for patients with chronic nausea, with or without vomiting, that have normal gastric emptying.
Interventions
- DEVICE Enterra Therapy System
Study Locations (17)
Other
- UZ Leuven - Leuven
- Hôpital Louis-Mourier - Colombes
- Hôpital Edouard Herriot - CHU de Lyon - Lyon
- CHU de Bordeaux - Pessac
- CHU de Rouen - Rouen
- Sahlgrenska Universitetssjukhuset - Gothenburg
California
- Hoag Hospital - Newport Beach
- Sutter Health - San Francisco
Arizona
- Mayo Clinic Arizona - Scottsdale
Florida
- University of South Florida - Tampa
Illinois
- Endeavor Health - Evanston
Indiana
- Indiana University Health - Indianapolis
Kentucky
- University of Louisville - Louisville
New Jersey
- Hackensack Meridian - Neptune City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2025-06-23 |
| Est. Completion | 2030-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06464926
The ClinicalTrials.gov registry entry for NCT06464926 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 235-participant average among 17 other Nausea trials with a reported enrollment target (37% lower). The listed sponsor is Enterra Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Nausea appearing as the primary indexed condition, and to 1 intervention - of which Enterra Therapy System is the first listed.
NCT06464926 reports 17 study locations spanning 11 distinct geographic areas - top geographies include Other, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT06464926 about?
NCT06464926 is a clinical study titled "Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)". The purpose of this research study is to determine if the Enterra® Therapy System can decrease nausea and vomiting symptoms and improve the quality of life for patients with chronic nausea, with or without vomiting, that have normal gastric emptying.
What is the current status of trial NCT06464926?
This trial is currently recruiting. It is a NA study. The enrollment target is 148 participants. The study started on 2025-06-23. Estimated completion is 2030-06.
What conditions does trial NCT06464926 study?
This clinical trial studies the following conditions: Nausea, Vomiting.
What interventions are being tested in trial NCT06464926?
The interventions under investigation include: Enterra Therapy System (DEVICE).
Who is sponsoring clinical trial NCT06464926?
This trial is sponsored by Enterra Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06464926 being conducted?
This trial has 17 study locations across Arizona, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nausea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
RECRUITING · NA
-
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
RECRUITING · NA
-
Acupressure Wristbands for GLP-1RA Related Nausea
ACTIVE NOT RECRUITING · NA
-
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
COMPLETED · NA
-
Virtual Reality at End-of-life
COMPLETED · NA
-
Inhaled Isopropyl Alcohol for Treatment of Nausea
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.